{
    "hands_on_practices": [
        {
            "introduction": "The accumulation of senescent cells is a fundamental hallmark of aging. This process can be modeled as a dynamic equilibrium between the constant rate of senescent cell induction and the rate of their clearance by the immune system. This exercise  provides a hands-on opportunity to construct a quantitative model from first principles, allowing you to understand how senescent cell burden changes with age and to predict the steady-state impact of a therapeutic intervention like a senolytic drug.",
            "id": "4426355",
            "problem": "Aging tissues accumulate senescent cells due to ongoing cellular damage and imperfect immune surveillance. Consider a single-compartment tissue in which the fraction of cells that are senescent, denoted by $S(t)$, changes over chronological age $t$ according to two processes grounded in conservation of mass and first-order kinetics: (i) a constant induction of senescent cells at a rate $ \\lambda $ (per year), reflecting the average rate of new senescent cell formation due to damage and stress; and (ii) immune-mediated clearance that removes senescent cells at a rate proportional to their current burden, with proportionality constant $ \\mu $ (per year). \n\nStarting from these principles, first construct the ordinary differential equation governing $S(t)$ and solve it for $S(t)$ given the initial condition $S(0)=0$, corresponding to negligible senescent burden at birth. Then, a senolytic therapy is introduced at age $t=T$ that improves immune clearance multiplicatively by a factor $f>1$ without altering the induction rate $ \\lambda $. Assume parameter values $ \\lambda = 0.0034 $ per year, $ \\mu = 0.27 $ per year, $ f = 1.5 $, and $ T = 50 $ years. Using your derived model, determine the steady-state senescent burden achieved under the senolytic-enhanced clearance (that is, the long-time limit after therapy is initiated). Express your final answer as a decimal fraction (no percentage sign). Round your answer to four significant figures.",
            "solution": "We formalize the dynamics of senescent cell burden by applying a conservation principle: the time rate of change of the senescent fraction equals the inflow (induction) minus the outflow (clearance). Let $S(t)$ denote the fraction of senescent cells at age $t$. The induction term is taken as a constant $ \\lambda $ (units: per year), representing a steady generation of senescent cells driven by cumulative damage. Clearance is modeled as first-order in the burden, so the removal rate is proportional to $S(t)$ with constant $ \\mu $ (units: per year). Therefore, the governing ordinary differential equation (ODE) is\n$$\n\\frac{dS}{dt} = \\lambda - \\mu S(t).\n$$\nThis is a linear first-order ODE with constant coefficients. Solving with an integrating factor or recognizing the standard form yields the general solution\n$$\nS(t) = \\frac{\\lambda}{\\mu} + \\left(S(0) - \\frac{\\lambda}{\\mu}\\right)\\exp(-\\mu t).\n$$\nGiven the initial condition $S(0)=0$, this simplifies to\n$$\nS(t) = \\frac{\\lambda}{\\mu}\\left(1 - \\exp(-\\mu t)\\right).\n$$\nThis expression predicts the age-dependent accumulation approaching an asymptote as $t \\to \\infty$. The steady-state (long-time) burden prior to any therapy is obtained by taking $t \\to \\infty$:\n$$\nS_{\\text{ss, baseline}} = \\lim_{t \\to \\infty} S(t) = \\frac{\\lambda}{\\mu}.\n$$\nNow introduce senolytic therapy at age $t=T$, which increases the clearance rate multiplicatively by a factor $f>1$. Under therapy, the new clearance constant is $ \\mu_{\\text{therapy}} = f \\mu $, while the induction rate remains $ \\lambda $. The post-therapy dynamics satisfy\n$$\n\\frac{dS}{dt} = \\lambda - (f\\mu) S(t),\n$$\nwith a steady-state (long-time limit after therapy initiation) given by\n$$\nS_{\\text{ss, therapy}} = \\frac{\\lambda}{f \\mu}.\n$$\nNote that this steady-state does not depend on $T$ because it is a long-time limit under the altered parameters, although the transient trajectory after $t=T$ does depend on the value of $S(T)$. The problem specifically requests the steady-state under therapy.\n\nSubstituting the given parameter values $ \\lambda = 0.0034 $ per year, $ \\mu = 0.27 $ per year, and $ f = 1.5 $, we obtain\n$$\nS_{\\text{ss, therapy}} = \\frac{0.0034}{1.5 \\times 0.27} = \\frac{0.0034}{0.405}.\n$$\nTo compute this ratio, observe that\n$$\n\\frac{0.0034}{0.405} = \\frac{34 \\times 10^{-4}}{405 \\times 10^{-3}} = \\frac{34}{4050} = \\frac{17}{2025} \\approx 0.008395061728\\ldots\n$$\nRounding this decimal fraction to four significant figures yields\n$$\n0.008395.\n$$\nTherefore, the steady-state senescent burden under senolytic-enhanced clearance, expressed as a decimal fraction, is $0.008395$ when rounded to four significant figures.",
            "answer": "$$\\boxed{0.008395}$$"
        },
        {
            "introduction": "Aging affects the function of every organ, with significant clinical consequences, and the progressive decline in kidney function is a classic example. This physiological change directly impacts how drugs are cleared from the body, a core concept in the field of pharmacokinetics. This practice problem  challenges you to connect a simple linear model of physiological decline to a critical, real-world clinical task: adjusting medication dosage in frail older adults to maintain therapeutic levels while avoiding toxicity.",
            "id": "4426436",
            "problem": "An orally administered drug used in frail older adults is eliminated by first-order kinetics through both renal and nonrenal pathways. Let the age-related decline in glomerular filtration rate (GFR) be modeled as a linear function of time $t$ (in years) since a baseline adult state: $GFR(t) = GFR_0 - k t$. Assume that renal drug clearance is proportional to $GFR(t)$ and that nonrenal clearance is constant with respect to age. The therapeutic goal is to maintain a constant long-term average steady-state plasma concentration.\n\nAt baseline ($t=0$), the following data are known and physiologically plausible for a standard adult:\n- Baseline glomerular filtration rate $GFR_0 = 100$ mL per min.\n- GFR decline slope $k = 0.9$ mL per min per year.\n- Total systemic clearance $Cl_{\\text{tot},0} = 6.0$ L per hr.\n- The renal pathway accounts for a fraction $0.60$ of $Cl_{\\text{tot},0}$ at baseline.\n- Oral bioavailability $F = 0.80$.\n- Dosing interval $\\tau = 12$ hr.\n- Target average steady-state concentration $C^{\\ast} = 10$ mg per L.\n\nUse the following core principles as your starting point: (i) definition of clearance for first-order elimination as $Cl = \\text{rate of elimination}/\\text{concentration}$, (ii) at steady-state the long-term average input rate equals the long-term average elimination rate, and (iii) total clearance is the sum of renal and nonrenal clearances. Derive, from these principles, an expression for the required maintenance dose per dosing interval at time $t$ that maintains $C^{\\ast}$ despite age-related changes in GFR. Then compute the adjusted maintenance dose (in mg per $12$ hr) for a frail elder at $t = 30$ years since baseline, assuming the stated model and parameters.\n\nExpress the final adjusted dose in mg and round your answer to four significant figures.",
            "solution": "The solution begins with the core principle of steady-state pharmacokinetics (Principle ii), which states that the average rate of drug administration equals the average rate of drug elimination.\n\nThe average rate of drug administration (Rate In) for an orally administered drug is given by:\n$$\n\\text{Rate In} = \\frac{F \\cdot D(t)}{\\tau}\n$$\nwhere $D(t)$ is the maintenance dose at time $t$, $F$ is the oral bioavailability, and $\\tau$ is the dosing interval.\n\nThe average rate of drug elimination (Rate Out) at steady-state is the product of the total systemic clearance at time $t$, $Cl_{\\text{tot}}(t)$, and the target average steady-state plasma concentration, $C^{\\ast}$:\n$$\n\\text{Rate Out} = Cl_{\\text{tot}}(t) \\cdot C^{\\ast}\n$$\nThis is a direct application of Principle (i).\n\nEquating the two rates at steady-state:\n$$\n\\frac{F \\cdot D(t)}{\\tau} = Cl_{\\text{tot}}(t) \\cdot C^{\\ast}\n$$\nSolving for the maintenance dose $D(t)$ gives the general equation:\n$$\nD(t) = \\frac{Cl_{\\text{tot}}(t) \\cdot C^{\\ast} \\cdot \\tau}{F}\n$$\nTo make this expression useful, we must derive an explicit formula for $Cl_{\\text{tot}}(t)$.\n\nAccording to Principle (iii), total clearance is the sum of renal and nonrenal clearances:\n$$\nCl_{\\text{tot}}(t) = Cl_{\\text{renal}}(t) + Cl_{\\text{nonrenal}}(t)\n$$\nThe problem states that nonrenal clearance is constant with age, so $Cl_{\\text{nonrenal}}(t) = Cl_{\\text{nonrenal},0}$, where the subscript $0$ denotes the baseline value at $t=0$.\n\nAt baseline ($t=0$):\n$Cl_{\\text{tot},0} = Cl_{\\text{renal},0} + Cl_{\\text{nonrenal},0}$\nWe are given that the renal pathway accounts for a fraction $f_r = 0.60$ of the total clearance at baseline. Therefore:\n$$\nCl_{\\text{renal},0} = f_r \\cdot Cl_{\\text{tot},0}\n$$\n$$\nCl_{\\text{nonrenal},0} = Cl_{\\text{tot},0} - Cl_{\\text{renal},0} = (1 - f_r) \\cdot Cl_{\\text{tot},0}\n$$\nThe problem states that renal clearance is proportional to GFR: $Cl_{\\text{renal}}(t) = c \\cdot GFR(t)$ for some proportionality constant $c$. We can find $c$ using the baseline values:\n$$\nc = \\frac{Cl_{\\text{renal},0}}{GFR_0}\n$$\nThus, the renal clearance at time $t$ is:\n$$\nCl_{\\text{renal}}(t) = \\frac{Cl_{\\text{renal},0}}{GFR_0} \\cdot GFR(t)\n$$\nSubstituting the given linear model for GFR, $GFR(t) = GFR_0 - k t$:\n$$\nCl_{\\text{renal}}(t) = \\frac{Cl_{\\text{renal},0}}{GFR_0} \\cdot (GFR_0 - k t) = Cl_{\\text{renal},0} \\left(1 - \\frac{k t}{GFR_0}\\right)\n$$\nNow we can assemble the expression for total clearance at time $t$:\n$$\nCl_{\\text{tot}}(t) = Cl_{\\text{renal}}(t) + Cl_{\\text{nonrenal},0} = Cl_{\\text{renal},0} \\left(1 - \\frac{k t}{GFR_0}\\right) + Cl_{\\text{nonrenal},0}\n$$\nNow we will compute the numerical value for the dose at $t = 30$ years. The units must be handled consistently. We will use Liters (L) for volume and hours (hr) for time as the base units for clearance calculations.\n\nFirst, calculate the baseline renal and nonrenal clearances:\n$$\nCl_{\\text{renal},0} = f_r \\cdot Cl_{\\text{tot},0} = 0.60 \\cdot (6.0 \\text{ L/hr}) = 3.6 \\text{ L/hr}\n$$\n$$\nCl_{\\text{nonrenal},0} = (1 - f_r) \\cdot Cl_{\\text{tot},0} = (1 - 0.60) \\cdot (6.0 \\text{ L/hr}) = 2.4 \\text{ L/hr}\n$$\nNext, calculate the fractional decline in GFR at $t = 30$ years. The term $\\frac{k t}{GFR_0}$ is dimensionless as the units cancel:\n$$\n\\frac{k t}{GFR_0} = \\frac{(0.9 \\text{ mL/min/year}) \\cdot (30 \\text{ years})}{100 \\text{ mL/min}} = \\frac{27}{100} = 0.27\n$$\nNow, calculate the renal clearance at $t=30$ years:\n$$\nCl_{\\text{renal}}(30) = Cl_{\\text{renal},0} \\left(1 - \\frac{k t}{GFR_0}\\right) = (3.6 \\text{ L/hr}) \\cdot (1 - 0.27) = (3.6 \\text{ L/hr}) \\cdot 0.73 = 2.628 \\text{ L/hr}\n$$\nThe nonrenal clearance is constant:\n$$\nCl_{\\text{nonrenal}}(30) = Cl_{\\text{nonrenal},0} = 2.4 \\text{ L/hr}\n$$\nThe total clearance at $t=30$ years is the sum:\n$$\nCl_{\\text{tot}}(30) = Cl_{\\text{renal}}(30) + Cl_{\\text{nonrenal}}(30) = 2.628 \\text{ L/hr} + 2.4 \\text{ L/hr} = 5.028 \\text{ L/hr}\n$$\nFinally, calculate the required maintenance dose $D(30)$ to maintain the target concentration:\n$$\nD(30) = \\frac{Cl_{\\text{tot}}(30) \\cdot C^{\\ast} \\cdot \\tau}{F}\n$$\nSubstituting the numerical values:\n$$\nD(30) = \\frac{(5.028 \\text{ L/hr}) \\cdot (10 \\text{ mg/L}) \\cdot (12 \\text{ hr})}{0.80}\n$$\nThe units are consistent: $(\\text{L/hr}) \\cdot (\\text{mg/L}) \\cdot (\\text{hr}) = \\text{mg}$.\n$$\nD(30) = \\frac{603.36 \\text{ mg}}{0.80} = 754.2 \\text{ mg}\n$$\nThe problem asks for the answer to be rounded to four significant figures. The calculated value $754.2$ already has four significant figures.",
            "answer": "$$\n\\boxed{754.2}\n$$"
        },
        {
            "introduction": "Frailty is not a static condition but a dynamic process where individuals transition between states of robustness, pre-frailty, and frailty over time. These transitions can be modeled powerfully using a mathematical framework known as a Markov chain, which allows for the prediction of long-term population distributions across these health states. By analyzing a Markov chain model , you can quantitatively assess the population-level impact of an intervention designed to combat frailty, offering a robust method for evaluating public health strategies.",
            "id": "4426371",
            "problem": "An aging cohort is stratified by frailty into three states: robust ($R$), pre-frail ($P$), and frail ($F$), based on validated clinical criteria used in geriatric pathology (for example, low grip strength, slow gait speed, and exhaustion). A year-to-year evolution of the cohort is modeled as a Discrete-Time Markov Chain (DTMC) satisfying the memoryless property, with constant transition probabilities. The steady-state distribution $\\pi$ describes the long-run cross-sectional fraction of the population in each state.\n\nFundamental definitions and facts to use:\n- A DTMC with transition matrix $P$ has a stationary distribution $\\pi$ that satisfies $\\pi P = \\pi$ and $\\sum_{i} \\pi_{i} = 1$, provided the chain is irreducible and aperiodic.\n- The Markov property assumes the next state depends only on the current state, not on earlier states.\n\nBaseline transition matrix $P_{B}$ and an intervention transition matrix $P_{I}$ (representing a multidomain exercise and nutrition program targeting sarcopenia and mobility) are specified for the ordered states $(R,P,F)$ as follows:\n$$\nP_{B} \\;=\\;\n\\begin{pmatrix}\n0.86 & 0.12 & 0.02 \\\\\n0.20 & 0.65 & 0.15 \\\\\n0.03 & 0.10 & 0.87\n\\end{pmatrix},\n\\qquad\nP_{I} \\;=\\;\n\\begin{pmatrix}\n0.88 & 0.10 & 0.02 \\\\\n0.26 & 0.65 & 0.09 \\\\\n0.04 & 0.18 & 0.78\n\\end{pmatrix}.\n$$\nAssume both chains are irreducible and aperiodic.\n\nUsing only the fundamental definitions above, compute the absolute reduction in the steady-state frail fraction achieved by the intervention, defined as $\\Delta = \\pi_{F}^{(B)} - \\pi_{F}^{(I)}$, where $\\pi^{(B)}$ and $\\pi^{(I)}$ are the stationary distributions under $P_{B}$ and $P_{I}$, respectively, and $\\pi_{F}$ denotes the frail component. Express $\\Delta$ as a decimal and round your final answer to four significant figures. Do not use a percent sign.",
            "solution": "The problem requires the computation of the absolute reduction in the steady-state frail fraction of a population, modeled by a Discrete-Time Markov Chain (DTMC), when an intervention is applied. The reduction is given by $\\Delta = \\pi_{F}^{(B)} - \\pi_{F}^{(I)}$, where $\\pi_{F}^{(B)}$ and $\\pi_{F}^{(I)}$ are the frail components of the stationary distributions for the baseline and intervention scenarios, respectively.\n\nA stationary distribution $\\pi$ for a DTMC with transition matrix $P$ is a left eigenvector of $P$ with an eigenvalue of $1$. It must satisfy the system of linear equations:\n$$ \\pi P = \\pi $$\nsubject to the normalization condition:\n$$ \\sum_{i} \\pi_{i} = 1 $$\nLet the states be ordered as $(R, P, F)$. The stationary distribution is a row vector $\\pi = (\\pi_R, \\pi_P, \\pi_F)$.\n\nFirst, we compute the stationary distribution $\\pi^{(B)}$ for the baseline transition matrix $P_B$.\n$$\nP_{B} \\;=\\;\n\\begin{pmatrix}\n0.86 & 0.12 & 0.02 \\\\\n0.20 & 0.65 & 0.15 \\\\\n0.03 & 0.10 & 0.87\n\\end{pmatrix}\n$$\nThe equation $\\pi^{(B)} P_B = \\pi^{(B)}$ gives the following system of equations, where we denote $\\pi^{(B)}$ as $(\\pi_R, \\pi_P, \\pi_F)$ for simplicity:\n1. $0.86 \\pi_R + 0.20 \\pi_P + 0.03 \\pi_F = \\pi_R$\n2. $0.12 \\pi_R + 0.65 \\pi_P + 0.10 \\pi_F = \\pi_P$\n3. $0.02 \\pi_R + 0.15 \\pi_P + 0.87 \\pi_F = \\pi_F$\n\nThese can be rearranged into a homogeneous system $(P_B^T - I)\\pi^T = 0$:\n1. $-0.14 \\pi_R + 0.20 \\pi_P + 0.03 \\pi_F = 0$\n2. $0.12 \\pi_R - 0.35 \\pi_P + 0.10 \\pi_F = 0$\n3. $0.02 \\pi_R + 0.15 \\pi_P - 0.13 \\pi_F = 0$\n\nSince these three equations are linearly dependent, we use any two of them along with the normalization condition $\\pi_R + \\pi_P + \\pi_F = 1$. Let's use the first two rearranged equations.\nFrom $\\pi_R = 1 - \\pi_P - \\pi_F$, we substitute into the first equation:\n$$ -0.14 (1 - \\pi_P - \\pi_F) + 0.20 \\pi_P + 0.03 \\pi_F = 0 $$\n$$ -0.14 + 0.14 \\pi_P + 0.14 \\pi_F + 0.20 \\pi_P + 0.03 \\pi_F = 0 $$\n$$ 0.34 \\pi_P + 0.17 \\pi_F = 0.14 $$\nDividing by $0.17$, we obtain a simpler relation:\n$$ 2 \\pi_P + \\pi_F = \\frac{0.14}{0.17} = \\frac{14}{17} $$\nNext, we substitute $\\pi_R = 1 - \\pi_P - \\pi_F$ into the second equation:\n$$ 0.12 (1 - \\pi_P - \\pi_F) - 0.35 \\pi_P + 0.10 \\pi_F = 0 $$\n$$ 0.12 - 0.12 \\pi_P - 0.12 \\pi_F - 0.35 \\pi_P + 0.10 \\pi_F = 0 $$\n$$ -0.47 \\pi_P - 0.02 \\pi_F = -0.12 $$\n$$ 47 \\pi_P + 2 \\pi_F = 12 $$\nWe now have a system of two equations for $\\pi_P$ and $\\pi_F$. From $2 \\pi_P + \\pi_F = \\frac{14}{17}$, we have $\\pi_F = \\frac{14}{17} - 2\\pi_P$. Substituting this into the second equation:\n$$ 47 \\pi_P + 2\\left(\\frac{14}{17} - 2\\pi_P\\right) = 12 $$\n$$ 47 \\pi_P + \\frac{28}{17} - 4\\pi_P = 12 $$\n$$ 43 \\pi_P = 12 - \\frac{28}{17} = \\frac{12 \\times 17 - 28}{17} = \\frac{204 - 28}{17} = \\frac{176}{17} $$\n$$ \\pi_P = \\frac{176}{17 \\times 43} = \\frac{176}{731} $$\nNow we find $\\pi_F$:\n$$ \\pi_F = \\frac{14}{17} - 2\\left(\\frac{176}{731}\\right) = \\frac{14 \\times 43}{17 \\times 43} - \\frac{352}{731} = \\frac{602 - 352}{731} = \\frac{250}{731} $$\nSo, the baseline frail fraction is $\\pi_{F}^{(B)} = \\frac{250}{731}$.\n\nNext, we compute the stationary distribution $\\pi^{(I)}$ for the intervention transition matrix $P_I$.\n$$\nP_{I} \\;=\\;\n\\begin{pmatrix}\n0.88 & 0.10 & 0.02 \\\\\n0.26 & 0.65 & 0.09 \\\\\n0.04 & 0.18 & 0.78\n\\end{pmatrix}\n$$\nThe equation $\\pi^{(I)} P_I = \\pi^{(I)}$ yields a new system of equations for $\\pi^{(I)} = (\\pi_R, \\pi_P, \\pi_F)$:\n1. $-0.12 \\pi_R + 0.26 \\pi_P + 0.04 \\pi_F = 0$\n2. $0.10 \\pi_R - 0.35 \\pi_P + 0.18 \\pi_F = 0$\nUsing $\\pi_R = 1 - \\pi_P - \\pi_F$, we substitute into the first equation:\n$$ -0.12 (1 - \\pi_P - \\pi_F) + 0.26 \\pi_P + 0.04 \\pi_F = 0 $$\n$$ -0.12 + 0.12 \\pi_P + 0.12 \\pi_F + 0.26 \\pi_P + 0.04 \\pi_F = 0 $$\n$$ 0.38 \\pi_P + 0.16 \\pi_F = 0.12 $$\n$$ 19 \\pi_P + 8 \\pi_F = 6 $$\nNext, substituting into the second equation:\n$$ 0.10 (1 - \\pi_P - \\pi_F) - 0.35 \\pi_P + 0.18 \\pi_F = 0 $$\n$$ 0.10 - 0.10 \\pi_P - 0.10 \\pi_F - 0.35 \\pi_P + 0.18 \\pi_F = 0 $$\n$$ -0.45 \\pi_P + 0.08 \\pi_F = -0.10 $$\n$$ 45 \\pi_P - 8 \\pi_F = 10 $$\nWe now solve the system for $\\pi_P$ and $\\pi_F$:\n$$ 19 \\pi_P + 8 \\pi_F = 6 $$\n$$ 45 \\pi_P - 8 \\pi_F = 10 $$\nAdding the two equations eliminates $\\pi_F$:\n$$ (19 + 45) \\pi_P = 6 + 10 $$\n$$ 64 \\pi_P = 16 \\implies \\pi_P = \\frac{16}{64} = \\frac{1}{4} $$\nSubstituting $\\pi_P = \\frac{1}{4}$ into $19 \\pi_P + 8 \\pi_F = 6$:\n$$ 19\\left(\\frac{1}{4}\\right) + 8 \\pi_F = 6 $$\n$$ 8 \\pi_F = 6 - \\frac{19}{4} = \\frac{24 - 19}{4} = \\frac{5}{4} $$\n$$ \\pi_F = \\frac{5}{32} $$\nSo, the intervention frail fraction is $\\pi_{F}^{(I)} = \\frac{5}{32}$.\n\nFinally, we compute the absolute reduction $\\Delta$:\n$$ \\Delta = \\pi_{F}^{(B)} - \\pi_{F}^{(I)} = \\frac{250}{731} - \\frac{5}{32} $$\nTo evaluate this, we convert the fractions to decimal form:\n$$ \\pi_{F}^{(B)} = \\frac{250}{731} \\approx 0.34199726... $$\n$$ \\pi_{F}^{(I)} = \\frac{5}{32} = 0.15625 $$\n$$ \\Delta \\approx 0.34199726 - 0.15625 = 0.18574726... $$\nThe problem requires the answer to be rounded to four significant figures. The first four significant figures are $1$, $8$, $5$, and $7$. The fifth digit is $4$, so we round down.\n$$ \\Delta \\approx 0.1857 $$",
            "answer": "$$\\boxed{0.1857}$$"
        }
    ]
}